Spur Therapeutics Competitors and Similar CompaniesClear all
Spur Therapeutics's competitors and similar companies include Acorda Therapeutics, Codiak Biosciences, Polyplus-transfection and Right To Care.
 Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  Right To Care Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa. | |
Founding Date | Founding Date 2015 | Founding Date 1995 | Founding Date 2015 | Founding Date 2002 | Founding Date 2001 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Stevenage, GB HQ Boston, US New York, US | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Cambridge, US HQ | Locations Illkirch-Graffenstaden, FR HQ New York, US | |
Employees | Employees 122 | Employees 4742% decrease | Employees 992% decrease | Employees 1133% increase | Employees 1,817 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 821 k | Valuation ($) 2.8 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $15.3m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Net income | Net income ($89m) (FY, 2022) | Net income ($252.9m) (FY, 2023) | Net income ($37.2m) (FY, 2021) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 289.3m | Total funding raised N/A | Total funding raised $ 168.5m | Total funding raised $ 3.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Acorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companyPolyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View companyRight To Care
HQ
Centurion, ZA
Employees
1,817
Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa.
View company